We asked our analysts what findings from our physician studies really popped for them in 2017. Among the standouts: inbox overload prompting global pharma e-newsletter phatigue; an avalanche of stale details in the U.S.; and declining physician visits to pharma websites in the key emerging markets of China and Brazil.


DRG becomes Clarivate

View Now